Navigation Links
Medco Delivers Record Third-Quarter 2009 GAAP Diluted EPS of $0.69; Diluted EPS Excluding Amortization of Intangible Assets of $0.75
Date:11/3/2009

the Securities and Exchange Commission.




                           Medco Health Solutions, Inc.
                    Condensed Consolidated Statements of Income
                                    (Unaudited)
                      (In millions, except for per share data)

    Table 1.
                              Quarters Ended         Nine Months Ended
                          ----------------------  ----------------------
                          Sept. 26,   Sept. 27,   Sept. 26,   Sept. 27,
                             2009        2008        2009        2008
                          ----------  ----------  ----------  ----------
      Product net revenues
       (Includes retail
        co-payments of
        $2,115 and $1,828
        in the third
        quarters of 2009
        and 2008, and
        $6,487 and $5,830
        in the nine months
        of 2009 and 2008)  $14,590.8   $12,390.3   $43,936.6   $37,804.3
      Service revenues         204.0       168.8       622.5       492.3
                          ----------  ----------  ----------  ----------
        Total net
         revenues           14,794.8    12,559.1    44,559.1    38,296.6
                          ----------  ----------  ----------  ----------

      Cost of operations:
        Cost of product
         net revenues
         (Includes retail
          co-payments of
          $2,115 and
          $1,828 in the
          third quarters
          of 2009 and 2008,
          and $6,487 and
          $5,830 in the
          nine months of
          2009 and 2008)    13,696.5    11,580.7    41,384.7    35,391.5
        Cost of service
         revenues               58.3        53.6       174.6       146.7
                          ----------  ----------  ----------  ----------
          Total cost of
           revenues         13,754.8    11,634.3    41,559.3    35,538.2
        Selling, general
         and
         administrative
         expenses              369.0     
'/>"/>
SOURCE Medco Health Solutions, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29

Related medicine technology :

1. Medco to Present at November 2009 Investor Conferences
2. The Medco Foundation Joins With the Entertainment Industry Foundation to Give Health a Hand to Communities in Need
3. Medcos 2010 Medicare Prescription Drug Plan Helps People Take an Active Part in Lowering Prescription Costs
4. Medco Announces Date for Third-Quarter 2009 Financial Results; Company to Provide 2010 Earnings Guidance
5. Siemens Delivers Flash Speed, Lowest Dose to Arnold Palmer Hospital for Children
6. Varian, Inc. Delivers a Productivity Increase of Up to 100% With Its 710-ES Series ICP-OES
7. Ethicon Endo-Surgery Launches New Echelon Flex(TM) Endopath(R) Stapler That Delivers Echelon(TM) Compression, Now With Natural Articulation
8. Hoviones TwinCaps(R) Inhaler Delivers Successfully in Phase III Clinical Trials for Influenza
9. Vtech(R) Delivers Todays Hottest Trends to Tech-Savvy Kids
10. VivoMetrics(R) Introduces Next Generation LifeShirt Prototype, a Smart Garment That Delivers Real-time Vital Signs Remotely to Healthcare Providers
11. VELCADE(R) (Bortezomib) for Injection Based Treatment Delivers Impressive Complete Response and Survival in Patients With Newly Diagnosed Multiple Myeloma

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)... Nov. 30 Reportlinker.com announce...n its catalogue: ,, Diabetes Diagnostics - A G...linker.com/p0164347/Diabetes-Diagnostics---A-Globa...is market is driven by a steady increase in the nu...e developed and developing parts of the world, and...
(Date:11/30/2009)..., Mich., Nov. 30 eHealthSource.com... exclusively to products approved for Flexible Spe...claims. The site is also the first to exclusively...saving shoppers up to 75 percent on everyday healt...common healthcare headaches - high costs and compl...
(Date:11/30/2009)...ass., Nov. 30 According to Millenn...medical technology market intelligence, the nearly...ined by almost 5% over 2008 as patients chose to d...ic crisis. The market will, however, begin recover...pre-recession growth rates of over 15%. MRG,s faci...
Breaking Medicine Technology:Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 2Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 3Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 4Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 5Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 6Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 7Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 8Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 9eHealthSource.com Launches Online Shopping Site Dedicated to Over-the Counter Medications Approved for FSA/HSA Claims 2Facial Injectables Emerge From the Recession 2Facial Injectables Emerge From the Recession 3Par Pharmaceutical Announces Extension and Increase in Maximum Purchase Price for Modified Dutch Auction Tender Offer to Purchase up to 2465 000 000 6103 1Par Pharmaceutical Announces Extension and Increase in Maximum Purchase Price for Modified Dutch Auction Tender Offer to Purchase up to 2465 000 000 6103 2Par Pharmaceutical Announces Extension and Increase in Maximum Purchase Price for Modified Dutch Auction Tender Offer to Purchase up to 2465 000 000 6103 3Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 6101 1Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 6101 2Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 6101 3Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 6101 4Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 6101 5Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 6101 6Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 6101 7Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 6101 8Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 6101 9Obesity Seems to Alter Heart Structure 61019 1
..., April 26 Schering-Plough Corporation,(NYSE: SG...erim analysis of,an ongoing Phase II study of boce...ase inhibitor, in 595 treatment-naive patients wit...presented at the 43rd Annual,Meeting of the Europe...The,ongoing study evaluates boceprevir in 28-week ...
...ril 25 Delcath Systems, Inc.,(Nasdaq: DCTH ) ann...IRB) of,the University of Maryland Medical Center ...ase III study of the Company,s Percutaneous Hepati...se delivery of the,anti-cancer agent melphalan to ... The pivotal, Phase III study is being led by the ...
Other Medicine Technology:Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment-Naive Hepatitis C Patients Presented At EASL 2Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment-Naive Hepatitis C Patients Presented At EASL 3Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment-Naive Hepatitis C Patients Presented At EASL 4Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment-Naive Hepatitis C Patients Presented At EASL 5Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment-Naive Hepatitis C Patients Presented At EASL 6Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment-Naive Hepatitis C Patients Presented At EASL 7Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment-Naive Hepatitis C Patients Presented At EASL 8Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment-Naive Hepatitis C Patients Presented At EASL 9Delcath Expands Phase III Trial for Metastatic Melanoma to Include University of Maryland Medical Center 2Delcath Expands Phase III Trial for Metastatic Melanoma to Include University of Maryland Medical Center 3Delcath Expands Phase III Trial for Metastatic Melanoma to Include University of Maryland Medical Center 4
(Date:11/30/2009)... , ATLANTA, Nov. 30 Kool Smi...Initiative," with national recognition as one of...by Chief Technical Architect, Mark Blomquist, Kool...ure to support the electronic health records syste...es. With this roll-out now complete, Kool Smiles ...
(Date:11/30/2009)... , SEATTLE, Nov. 30 Major Lea... for the Kansas City Royals and recently acquired ...tch Award(®). The award is given annually to ...s the honor, courage and dedication of baseball gr... ,, The 28-year-old Redlands, Calif., native ma...
(Date:11/30/2009)...te highest for lifelong residents of ,stroke belt,...althDay News) -- People born in the "stroke belt" ...er risk of dying of stroke than others, even if th...ata on both black and white people born in the Nor...s, Mississippi and Alabama show a consistently hig...
(Date:11/30/2009)...andemic seems to ebb, CDC notes a rise in child de... (HealthDay News) -- U.S. health officials said M...on the wane nationally, even as the number of Amer...rise. , The latest report, released Monday by t... (CDC), finds that "visits to doctors for influenz...
(Date:11/30/2009)... , CARDIFF, Calif., Nov. 30 /PRNewswire-FirstC....jedimindinc.com) is pleased to announce the Compa... available for purchase. The game, "Think-Tac-Toe"...o play the game with the power of their mind and i... be sold online at a price of $49 and can be purch...
Breaking Medicine News(10 mins):Health News:Kool Smiles Named Among 2009 InfoWorld 100 2Health News:Mark Teahen Named 2009 Hutch Award Winner 2Health News:Birth in South Raises Stroke Risk for Life 2Health News:Birth in South Raises Stroke Risk for Life 3Health News:U.S. Swine Flu Cases Chart Sharp Decline 2Health News:U.S. Swine Flu Cases Chart Sharp Decline 3Health News:First Thought-Controlled Game Complete From Jedi Mind, Inc. 2
...p.m. Eastern Time Today -, IRVINE, Calif., March ...wide leader in intravascular patient temperature,m...te progress and,financial results for the fourth q...rter of 2006. Revenue for the,full year 2007 was a...
... than teens, a new study finds, , , THURSD...causes signs of cardiovascular damage in children,...ds. , The findings, which focused on children from...ry, suggesting an increased risk of heart disease....
...osciences,(Nasdaq: MATK ) announced today that li...omega 3 for brain, eye and heart health, is availa...Heart & Mind juice-blend from,National Foods, Aust...ice beverages sold in the country. Sold in major,r...
...ncy for,Healthcare Research and Quality has awarde...logy contracts that will focus on the development,...actices using clinical,decision support. Clinical ...ool,of Medicine in New Haven, CT, have been select...
...toddlers given combined shot; experts stress real ...(HealthDay News) -- U.S. health officials are no l...mumps, rubella and varicella) vaccine over the MMR...in children aged 12 to 23 months. Preliminary find...
...ly increase the amount of physical activity among ...rom the Trial of Activity for Adolescent Girls (TA...ted by the National Heart, Lung, and Blood Institu...e March issue of the American Journal of Preventiv...
Other Medicine News:Health News:Alsius Corporation Reports Record Fourth Quarter and Full Year 2007 Financial Results 2Health News:Alsius Corporation Reports Record Fourth Quarter and Full Year 2007 Financial Results 3Health News:Alsius Corporation Reports Record Fourth Quarter and Full Year 2007 Financial Results 4Health News:Alsius Corporation Reports Record Fourth Quarter and Full Year 2007 Financial Results 5Health News:Alsius Corporation Reports Record Fourth Quarter and Full Year 2007 Financial Results 6Health News:Alsius Corporation Reports Record Fourth Quarter and Full Year 2007 Financial Results 7Health News:Alsius Corporation Reports Record Fourth Quarter and Full Year 2007 Financial Results 8Health News:Secondhand Smoke Hikes Tots' Risk of Heart Disease 2Health News:Secondhand Smoke Hikes Tots' Risk of Heart Disease 3Health News:Australia's Leading Juice Company Launches Juice Blend with Martek's life'sDHA(TM) 2Health News:Australia's Leading Juice Company Launches Juice Blend with Martek's life'sDHA(TM) 3Health News:AHRQ Awards $5 Million to Help Integrate Clinical Decision Support Technologies Into Health Care Delivery 2Health News:U.S. Health Officials Back Off Preference for New MMRV Vaccine 2Health News:U.S. Health Officials Back Off Preference for New MMRV Vaccine 3Health News:After-school programs can increase physical activity of adolescent girls 2
Welch Allyn 3.5v AutoStep Coaxial Ophthalmoscope Head Only
Welch Allyn Video Direct Ophthalmoscope (Head Only)
2.5v PocketScope with Handle and Rechargeable Battery
Welch Allyn 2.5v PocketScope Ophthalmoscope with AA battery handle
Medicine Products: